The CDC and FDA have confirmed the presence of a fungus known as Exserohilum rostratum in unopened medication vials of preservative-free methylprednisolone acetate (80mg/ml) from one of the three implicated lots from NECC (Lot #08102012@51, BUD 2/6/2013).
The laboratory confirmation further links steroid injections from these lots from New England Compounding Center (NECC) to the multistate outbreak of fungal meningitis and joint infections. Testing on the other two implicated lots of methylprednisolone acetate and other NECC injectables continues.
The CDC and state health departments estimate that approximately 14,000 patients may have received injections with medication from three implicated lots of methylprednisolone and nearly 97% of these patients have been contacted for further follow-up.
A Patient Notification Letter is now available from the FDA for health care professionals to use to notify patients that the drug has been recalled.
October 18, 2012 — FDA safety alert and statement